Arvinas Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ARVN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Feb 24	SellUS$79,938	Ronald Peck	Individual	1,699	US$47.05
23 Feb 24	SellUS$244,472	John Houston	Individual	5,196	US$47.05
23 Feb 24	SellUS$80,079	Sean Cassidy	Individual	1,702	US$47.05
23 Feb 24	SellUS$80,032	Ian Taylor	Individual	1,701	US$47.05

Insider Buying: ARVN insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.2%.

Top 25 shareholders own 75.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.85%	EcoR1 Capital, LLC	6,726,491	US$234.8m	23%	7.52%
7.84%	BlackRock, Inc.	5,354,864	US$186.9m	7.75%	no data
7.1%	The Vanguard Group, Inc.	4,851,390	US$169.3m	5.28%	no data
6.17%	RTW Investments, LP	4,213,483	US$147.1m	0%	2.64%
5.61%	T. Rowe Price Group, Inc.	3,832,123	US$133.7m	42.5%	0.01%
4.37%	Avidity Partners Management, L.P.	2,985,117	US$104.2m	14.2%	4.09%
3.67%	Bellevue Asset Management AG	2,507,731	US$87.5m	18%	1.0%
3.57%	Citadel Advisors LLC	2,439,981	US$85.2m	291%	0.09%
3.28%	FMR LLC	2,243,868	US$78.3m	-53.9%	0.01%
3.06%	JP Morgan Asset Management	2,091,317	US$73.0m	8.8%	0.01%
2.48%	Nextech Invest Ltd.	1,695,645	US$59.2m	490%	10.8%
2.3%	ArrowMark Colorado Holdings, LLC	1,569,895	US$54.8m	-24.8%	0.64%
1.89%	New Leaf Venture Partners, LLC	1,289,521	US$45.0m	0%	45.42%
1.74%	State Street Global Advisors, Inc.	1,186,474	US$41.4m	2.33%	no data
1.64%	Geode Capital Management, LLC	1,122,627	US$39.2m	6.17%	no data
1.46%	Commodore Capital LP	1,000,000	US$34.9m	0%	2.45%
1.36%	Paradigm Biocapital Advisors LP	931,303	US$32.5m	0%	1.65%
1.28%	Norges Bank Investment Management	877,708	US$30.6m	25.1%	no data
1.27%	John Houston	865,750	US$30.2m	-7.4%	no data
1.16%	Adage Capital Management, L.P.	789,485	US$27.6m	0%	0.05%
1.09%	Holocene Advisors, LP	744,465	US$26.0m	0%	0.1%
0.92%	VR Adviser, LLC	627,788	US$21.9m	0%	1.23%
0.89%	Tavistock Life Sciences	608,614	US$21.2m	0%	1.3%
0.86%	Morgan Stanley, Investment Banking and Brokerage Investments	586,517	US$20.5m	75.9%	no data
0.74%	Finepoint Capital LP	504,700	US$17.6m	0%	6.61%